Sai Parenterals' subsidiary has renewed a 3-year OTC Medicines Supply Agreement with a leading Australian pharmacy chain. The deal is valued at AUD 30 million, approx Rs. 204 Cr.
Sai Parenterals' subsidiary secured an exclusive OTC medicine supply agreement with Australia's leading pharmacy network. Contract value is AUD 20.2 million (INR 1300 Cr). Execution term is 7.5 years, extendable by 3 years.
Sai Parenterals secured a 10-year contract worth ₹104.5 Cr for anti-TB product supply to PILL CORP in the Philippines. Orders will be released periodically.
